Icahn Gives Name, $200 Million To Medical School

Nov 15 2012 | 2:36am ET

Long before he became a legendary corporate raider and hedge fund manager, Carl Icahn attended medical school. Now, his name will finally appear on a medical diploma—as the name of a medical school.

The Icahn Associates chief, who last year stopped managing outside capital, has pledged $200 million to the Mount Sinai School of Medicine in New York, which will be renamed the Icahn School of Medicine at Mount Sinai. Icahn, who serves on the school's board of directors, has already given $50 million to it, with the other $150 million to come.

Icahn said the gift, which will be primarily used to build research capacity, was influenced by both of his parents: He cited his father's socialist legacy and his mother's dream that her son would become a doctor. "It does help the people that aren't that fortunate," Icahn said of his new namesake.

Icahn also spoke of the two years he spent in medical school at New York University—a school now named for fellow financier Kenneth Langone—at his mother's urging. He "hated" the experience, he said, but added, "My mother would be proud of me today. My name is involved with a medical school."


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

Versum Materials (VSM), with a market capitalization of $2.7 billion, enables chipmakers to achieve higher performance at lower cost with enhanced reliability. Versum is a leading global provider of electronic materials for the integrated circuit and flat-panel display markets.